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Summary A new human embryonal rhabdomyosarcoma cell line, designated JR-1, is described that closely
resembles the tumour from which it was derived. Comparative studies, by light and electron microscopy
reveal morphological features such as myofibre formation, that are concordant with embryonal
rhabdomyosarcoma. Immunohistological investigations using a panel of monoclonal antibodies indicate that
the cell surface antigen profile of the JR-1 cell line is similar to other embryonal rhabdomyosarcomas. In
addition the cell line expresses the cytoplasmic intermediate filament protein desmin, only found in cells of
rhabdoid origin. Karyotyping JR-1 shows the cells to contain variable numbers of chromosomes (range 44-
100). DNA flow cytometry indicates that cells have an DNA content which is approximately twice normal.
The JR-1 cell line has a doubling time of 29h in culture and, in common with several other human cell lines,
produces xenografts in nude mice within 6 weeks of inoculation. With detailed studies on the original tumour
and the JR-1 cell line, the latter should prove an excellent model system for investigating the biology of
rhabdomyosarcoma.
Rhabdomyosarcoma is the commonest sarcoma in
childhood, accounting for between 4 and 8% of
malignant tumours in patients under 15 years of
age (Sutow et al., 1984). The most common
histological type of childhood rhabdomyosarcoma
is the embryonal variety. This consists mainly of
small cells, with round to oval nuclei and little
cytoplasm, and resemble the primitive mesenchymal
stem cell from which the tumour is thought to arise
(Enzinger & Weiss, 1983).
By conventional histological and cytological
techniques it is sometimes difficult to distinguish
rhabdomyosarcomas from other 'small round cell
tumours' of childhood, namely lymphoblastic
leukaemia/lymphoma, neuroblastoma and Ewing's
sarcoma (Reynolds et al., 1981; Triche & Askin,
1983). Whilst it is relatively simple to differentiate
neuroblastoma from lymphoblastic leukaemia/
lymphoma using panels of monoclonal antibodies,
this is not the case for either Ewing's sarcoma or
rhabdomyosarcoma (Kemshead et al., 1982). Few
in vitro cell lines are available to help in the search
for new reagents that can selectively identify
rhabdomyosarcomas from other 'small round cell'
tumours of childhood (McAllister et al., 1969, 1975;
Giard et al., 1973). We have systematically
attempted to establish new rhabdomyosarcoma cell
lines from biopsy and autopsy material. Here we
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describe one such cell line, JR-1, and demonstrate
that both its morphological appearance and
immunophenotype are analogous to the tissue from
which it was derived.
Materials and methods
Case report
The JR-1 cell line was established from tumour
material obtained at post mortem examination of a
7 year old girl. The patient first presented at the
Hospital for Sick Children, Gt. Ormond Street,
London, in May 1982, with a uterine neoplasm,
following 2-3 weeks of abdominal pain. Biopsy
revealed a tumour histologically classified as
embryonal rhabdomyosarcoma, believed to have
arisen from the left broad ligament. A computerised
tomography scan showed metastatic spread of the
tumour to the lungs. Following a regimen of
radiotherapy with vincristine, cyclophosphamide
and Actinomycin D, both the metastases and the
primary pelvic mass were notably diminished. In
January 1983 lung metastases of increasing size
were again observed, and the patient died in May.
Post mortem examination revealed a large, partially
necrotic, mass of primary tumour filling the pevlis,
and widespread, large metastases with no obvious
necrosis in the lungs, liver, adrenal, kidneys,
pancreas, rectum, bladder and peritoneum.
Histological assessment revealed the tumour to be a
poorly differentiated embryonal rhabdomyosarcoma.
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Establishment ofthe JR-I cell line
The tissue culture medium used throughout was
RPMI 1640 medium, supplemented with 10% foetal
calf serum (Gibco Europe Ltd.). 2mM glutamine
(Gibco), 100IU penicillin (Gibco) and 100pgml-1
streptomycin (Gibco).
A specimen of tumour taken from a lung
metastasis was washed in fresh medium and
chopped into 2-3mm pieces. These were distributed
between 25 cm2 plastic tissue culture flasks (Falcon)
containing 5.0ml of the above medium, and
incubated at 37°C in a 5% CO2 incubator.
After 1 week, half the culture medium was
replaced. Once sufficient cell growth had occurred
complete medium changes were made 3 times a
week. On confluency, cells were removed from the
dishes using trypsin/versene and subcultured 1:3
into new culture flasks. Cultures were frozen at
intervals in medium containing 10% foetal calf
serum (FCS) and 10% dimethyl sulphoxide
(DMSO) and stored in liquid nitrogen. Human
neuroblastoma cell lines with the prefix CHP were
obtained from Dr A.E. Evans, The Children's
Hospital, Philadelphia, and those with the prefix
SK from Dr L. Helson, Sloane Kettering Institute,
New York. Lan-l was obtained from Dr R. Seeger,
University of California, Los Angeles. TR14 from
Dr T. Rupniack, Imperial Cancer Research Fund,
London and 'Kelly' from Dr F. Gilbert, Mount
Sinai School of Medicine, New York. All of these
lines were grown in the above medium and screened
for antibody binding in the logarithmic phase of
growth.
Histological and ultrastructural studies
Tumour tissue was either fixed in 10% buffered
formalin for paraffin wax embedding or snap
frozen in liquid nitrogen and stored at -70°C.
Paraffin wax embedded tissue sections (5gm) were
cut and stained with haematoxylin and eosin.
Frozen sections (5gm) were mounted on glass
slides, air dried and fixed in methanol/acetone
(50/50, v/v) for 2min at -20°C.
Cells grown on coverslips were stained with H&E
for morphological examination. For indirect
immunofluorescence studies, cytocentrifuged
preparations of cells were air dried and fixed in
methanol/acetone as described above. Cells (2 x 106)
for electron microscopy were centrifuged at 350g to
form a pellet and fixed in 2.5% glutaraldehyde in
0.1M cacodylate buffer for 18 h at 4°C. The pellet
was washed twice in cacodylate buffer and
secondarily the pellet was again fixed in 1%
osmium tetroxide in cacodylate buffer. After
washing and dehydration using alcohol and
propylene oxide, samples were embedded in Epon
resin (Agar Aids, Essex, U.K.). Ultra-thin sections
were examined under a Joel 100c transmission
electron microscope.
Cytochemical and immunohistological procedures
Tissue sections and cytocentrifuge preparations were
stained with phosphotungstic acid haematoxylin
(PTAH) to demonstrate myofibres. Samples were
also treated with periodic acid-Schiff (PAS) staining
to detect glycogen granules.
For indirect immunofluorescence assays on cell
lines 5 x 105-106 cells were incubated for 30min at
4°C, with an excess of each monoclonal antibody
listed in Table I. Following washing, antibody
binding was demonstrated using fluorescein
conjugated goat anti-mouse immunoglobulin (Ig),
that was affinity purified and cross absorbed
against human Ig and pig liver powder. Samples
were analysed using a Zeiss Photomicroscope III
with epi-illumination optics.
C*hroo1osome analysis
JR-1 cells were accumulated at metaphase by the
addition of 1 Mgml - of vinblastine for 1 h during
the logarithmic phase of growth. Adherent cells
were detached from the flasks by trypsin/versene
treatment, washed and resuspended in 0.075M KCI
for 20min. Following fixation in 3 successive
washes of 3: 1 methanol:acetic acid, cells were
dropped onto microscope slides and flame dried.
G-banding was achieved by a one minute
incubation of slides in Hanks balanced salt solution
(HBSS) -Ca++, -Mg++ (HBSS, pH6.8) and
20mgml-1 trypsin in HBSS pH6.7. This was
followed by immersion in HBSS (pH5.7), a 4min
incubation in 5% Giemsa buffer (pH6.8) and
washing in deionized water.
Results
Tumour histology
Staining of the original uterine tumour revealed
mostly undifferentiated pleomorphic cells.
Occasional spindle and strap-shaped cells and some
multinucleated giant cells with strongly
eosinophillic cytoplasm were identified. Cells
contained round, oval or indented nuclei with
prominent nucleoli. Occasionally cytoplasmic
longitudinal fibres and cross striations were seen,
suggesting a diagnosis of embryonal rhabdomyo-
sarcoma. Primitive myofibres could be
demonstrated within the more differentiated tumour
cells by PTAH staining. Fine, but not abundant,
glycogen granules were found to be present by PAS
staining.HUMAN RHABDOMYOSARCOMA IN CULTURE 85
Table I Monoclonal antibodies used in the characterisation of the JR-1 cell line
Antibody Immunogen Antigen Reference
Desmin Commercial Desmin Debus (1983)
Vimentin Commercial Vimentin Osborn (1984)
Myoglobine Commercial Myoglobin Dako Products Ltd
FD 19.9 Human astrocytoma GFAPa Kemshead & Coakham (1983)
LE 61 Epithelial cells Cytokeratin Lane (1982)
RT 97 Rat brain extract Neurofilament Wood & Anderton (1981)
UJ13A Human foetal brain Glycolipid Allan et al. (1983)
UJI81.4 Human foetal brain NKb Kemshead et al. (1983)
UJ 127.11 Human foetal brain 220,000Mol.wt Gp. Kemshead et al. (1983)
UJ308 Human foetal brain NK Kemshead et al. (1982)
A2B5 Chick retinal cells Ganglioside Gq Eisenbarth et al. (1979)
Thy-I Purified Thy-I Thy-I Kemshead et al. (1982)
PI 153/3 Neuroblastoma cells p 20,000Mol.wt Kennett & Gilbert (1979)
5.1.H1i1 Myoblasts culture NK Hurko & Walsh (1983)
BAI Nalm6-MI-ALL cells NK Abramson et al. (1981)
BA2 Nalm6-MI-ALL cells p 24,000Mol.wtc Kersey et al. (1981)
BA3 Nalm6-MI-ALL cells 95,000Mol.wt.Gpd Le Bien et al. (1982)
W6/32 Human leucocytes Gp 44 & 12,000 Brodsky et al. (1979)
DA2 RKT Lymphoid line DR antigens Brodsky et al. (1980)
2D1 Human leucocytes 2000,000Mol.wtGp Beverley (1980)
aGlial Fibrillary Acidic Protein; bNot known; CProtein; dGlycoprotein and CHeteroantisera.
Anti-Desmin was purchased from Amersham Int. PLC; Vimentin was purchased from
Eurodiagnostics and Myoglobin was purchased from Dako Products.
Histology ofcultured cells
The cell line JR-1 shows pleomorphic histological
features similar to the tumour of origin with
considerable variety in the size and shape of cells.
Stellate cells predominate, whilst elongated, spindle-,
strap-shaped, rounded, oval and tadpole-shaped
cells can be identified (Figure 1). In addition a
small number of large multinucleated cells are
present - 1.0%).
In this population nuclei vary in shape between
round, oval and indented, and contain coarse
chromatin and either very prominent single or
multiple nucleoli (Figure 2A). The large
multinucleate cells have nucleoli, arranged either in
tandem or in a horseshoe distribution. The
cytoplasm of JR-1 cells shows fine stippled granules
staining positive with PAS, which disappear on
diastase digestion. This demonstrates the presence
of glycogen granules. Moderate numbers of mitotic
figures are present. The ample cytoplasm appears
granular and highly eosinophilic, although there is
considerable variation in the intensity of H&E
Figure 1 JR-1 cell line, morphology of individual cells. (a) stellate, (b) strap-shaped, (c) spindle, (d) large
multinucleated giant cell, (e) elongated cell with the nuclei arranged in tandem. (Haematoxylin and eosin,
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Figure 2 (A) Toluidine blue-stained semi-thin section, illustrating nuclear morphology characteristic of the
JR-1 cell line. (1) multinucleated giant cell containing nuclei arranged in horseshoe distribution with
prominent nucleoli; (2) cell with one round and one indented nucleus x nucleoli are prominent. ( x 600). (B)
Electron micrograph showing focal condensations of cytoplasmic myofibres suggestive of Z bands.
N =nucleus, CY =cytoplasm. ( x 20,000)
staining. PTAH staining shows the presence of
longitudinal fibrils and transverse striations (see
Figure 3 A-C).
Electron microscopy
Electron microscopy of the JR-1 line shows
rounded cells containing nuclei with granular
chromatin, and an abundant cytoplasm rich in
organelles (see Figure 2B).
The cytoplasm contains many mitochondria and
in some cells dilated cisternae are identified. In
concordance with the PAS staining, seen by light
microscopy, small numbers of cytoplasmic glycogen
granules are identified together with free ribosomes
a
and rough endoplasmic reticulum. Thick and thin
filaments are found in the majority of cells. These
show a relationship characteristic of actin and
myosin, both on longitudinal and transverse
section. In some areas fibres appear condensed, as
is seen in Z band formation (Figure 2B). There is
no evidence of epithelial features. In particular, the
cytoplasmic condensations lack the triplets of fused
microtubules seen in the basal bodies of cilia.
Growth kinetics
Cells taken at passage 44 and seeded into 15mm
diameter dishes at an initial concentration of either
10 or 3 x 104 cells/well exhibited exponential growth
with a doubling time of - 29h (data not presented).
Figure 3 A, B and C show 3 separate fields of JR-1 cells stained with phosphotungstic acid haematoxylin.
Arrows indicate cytoplasmic cross-striations (cs). ( x600)HUMAN RHABDOMYOSARCOMA IN CULTURE
Cytogenetics
Flow cytometry of mithromycin stained JR-I cells
was undertaken to estimate DNA content.
Peripheral blood lymphocytes were used to
calibrate the flow cytometer. These gave a
fluorescence peak at window 26 representative of
normal diploid cells (Figure 4). In contrast the JR-I
cell line gave peak fluorescence at window 48
indicative of a DNA content of approximately
twice normal.
Direct counting of 50 cells (passage 45) revealed
a chromosome number of between 44 and 100 (with
a modal number of 88). A low number of 'double
dots' resembling interstitial deletions (Savage, 1975)
were found in 10% of these cells.
G-banded karyotypic analysis was carried out on
10 cells, none of which were found to be identical.
The majority of chromosomes demonstrated a
normal banding pattern, no obvious Y chromosome
was present. Eighty percent of cells carried at
least one 'marker' chromosome of rearranged
material; 13q- occurred in 50% cells, often as an
homologous pair, lp- and der (10) occurred in
30% cells and lq-, 6q- and iso(llq) in 20%.
Despite the near tetraploid chromosome number,
normal chromosomes varied between cells from 0-8
copies.
Establishment ofa xenograft in nude mice
Injection of 5 x 106 cells s.c. into the flank of nude
mice produced tumour nodules at the site of
injection within 2 months of inoculation. The
morphological and immunological studies on these
tumours are in concordance with the JR-1 cell line
and the original tumour.
Immunohistological characteristic ofthe JR-I cell line
Indirect immunofluorescence studies were under-
taken with a variety of monoclonal antibodies to
characterise fully the JR-1 cell line. Using a panel
of antibodies to intermediate filaments 20-30%
4
PBL JR-1
Relative DNA Content
Figure 4 Flow cytometric analysis of mithromycin-
stained JR-1 cells produces a main GO/GI peak,
representing a mean DNA content of approximately
twice normal, compared with the peripheral blood
lymphocyte (PBL) control.
of the cells were shown to bind anti-desmin,
whereas almost all cells bound an anti-vimentin
monoclonal antibody (Table II). This pattern of
binding was identical to that seen on frozen
sections of the tumour from which JR-1 was
derived. In both cases no binding of antibodies to
glial fibrillary acidic protein (GFAP), neuro-
filaments or cytokeratin was detected. Eleven other
rhabdomyosarcomas also demonstrated a similar
pattern of intermediate filament expression
following immunohistological analysis. No binding
of an anti-myoglobin antibody was observed in
either the JR-1 line or tumour tissue, a finding
Table II Cytoplasmic antigen expression in rhabdomyosarcoma tumours and the JR-1 cell line
Anti Anti
Anti Anti GFAP Anti neurofilament Anti
desmin vimentin (FD 19.9) cytokeratin R797 myoglobin
JR- line ++a +
JR-1 tumour + +
Other
rhabdomyosarcomas 11/11 ND 0/11 0/11 0/11 ND
aPositive in 20-30% of cells.
ND-No data.
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consistent with the relatively undifferentiated nature
of the original tissue.
Table III shows the profile of cell surface
antigens expressed by the JR-1 cell line when
examined using a panel of monoclonal antibodies.
The antibody W6/32, recognising a monomorphic
determinant expressed on HLA ABC antigens, was
found to bind to both the cell line and tumour
tissue. In contrast no binding of DA2, an anti-DR
antibody, was detected. No other lymphoid markers
(2D1, PI 153/3, BAI, BA2, BA3) bound to the JR-1
cell line. BA2 has been shown to bind to other
'small round cell' tumours of childhood, viz some
neuroblastoma and Ewing's sarcoma cell lines.
However, some antibodies raised against neural
tissue (A2B5, UJ13A) and some others selected for
their binding to human neuroblastoma (anti Thy-1,
5.1.H1i) bound to the JR-1 cell line. Although
there is some heterogeneity in antigen expression
among the 12 human neuroblastoma lines studied,
the pattern of antibody binding to the JR-1
rhabdomyosarcoma line differs from neuroblastoma
(Table III).
Discussion
The pancity of human rhabdomyosarcoma cell lines
described to date, reflects the rare occurrence of the
tumour and the difficulty of establishing in vitro
lines from childhood solid tumours. It is parti-
cularly important to establish cell lines of this
tumour to investigate further its biology. Hopefully
this will lead to an increase in the survival rate of
children with this malignancy. The JR-1 cell line
described in this report resembles, as far as we can
determine, the tumour from which it was derived.
In addition, the morphology of this cell line is
similar to the previously published embryonal
rhabdomyosarcoma derived lines RD618, TE441
and the rhabdomyosarcoma line RDi 14
(McAllister, 1972). Of these, only JR-1 and RD618
show cytoplasmic banding following PTAH
staining, a feature supporting their rhabdoid
derivation.
Classification of tumours is possible by inter-
mediate filament typing (Osborn & Weber, 1983).
The pattern of intermediate filament expression
shown by JR-1 and other rhabdomyosarcomas
differs from that seen in other 'small round cell'
tumours of childhood. Neuroblastomas, particularly
those showing a degree of neural differentiation,
may contain neurofilaments, whereas Ewing's sar-
coma and hymphoid malignancies contain vimentin.
Desmin has proved useful in distinguishing sar-
comas of muscle cell origin from other soft tissue
sarcomas, and from childhood tumours of different
derivation (Attmansbergen et al., 1985). Our studies
show that over 20 samples of fresh neuroblastoma
and II of Ewing's sarcoma do not bind monoclonal
anti-desmin. Desmin was found in the JR-1 cell
line andin therhabdomyosarcoma cell line RD618. In
Table III Binding of a panel of monoclonal antibodies to the JR-I cell line and the tumour from
which it was derived
JR-I JR-I Other Human
Monoclonal rhabdomyosarcoma original tumour rhabdomyosarcoma neuroblastoma
antibody cell line tissue tumoursa cell linesb
UJ13A + + 11/11 11/11
UJ181.4 1/9 9/11
UJ127.11 1/6 10/11
UJ308 - 2/9 5/10
A2B5 + + 5/6 10/11
XThy-I + + 4/5 9/11
PI 153/3 3/6 11/11
5.1.Hll + + 11/11 11/11
BAI ND 0/3 11/11
BA2 ND ND 11/11
BA3 0/4 0/8
W6/32 + + 2/3 6/1ic
DA2 0/3 0/11
2D1 - 0/6 0/11
'All tumours used in this study were classified as embryonal rhabdomyosarcomas according to
the clinical features of the disease, histological and cytological studies and immunological
characterisation with anti-desmin and myoglobin; bCHP 100, CHP 212, CHP 126, CHP 134, Lan-1,
TR14, Kelly, SK-N-SH, SK-N-BE, SK-N-FL, SK-N-D2 and CWeak binding in the majority of
cases. ND-No data.HUMAN RHABDOMYOSARCOMA IN CULTURE 89
contrast, no binding was seen to rhabdomyosarcoma
derived cell lines A673 or A204. Neither did
A673 stain with antibody A2B5, or A204 with
UJ13A. Despite JR-1 binding A2B5, UJ13A and
other antibodies described as being 'neuroecto-
dermal' in specificity, the line is unquestionably
rhabdoid in nature. In addition to the data on
rhabdomyoblast-specific cell surface and intra-
cellular antigens (Tables 11-III), particles and
cytoplasmic banding are seen on PTAH staining
(Figure 2). Electron microscopy also reveals thick
and thin filaments and a tendency for Z bands to
form (Figure 3). These are definitive criteria for
the diagnosis of rhabdomyosarcoma (Toker, 1968).
In support of the proposed origin of JR-1, the
clinical presentation of this tumour arising in the
left broad ligament is not a recognised site of
occurrence of neuroblastoma.
Evidence of the establishment of JR-1 as a cell
line comes from continual growth of cells in culture
(currently to passage 58) and the ability of cells to
grow as a xenograft in nude mice (cells taken at
passage 44).
Unfortunately G banding and karyotypes of JR-1
has not revealed a consistent chromosomal marker
associated with the line. No consistent marker has
been described in rhabdomyosarcoma in the past,
although an increase in abberrations of
chromosome 3 has been suggested as being linked
with the malignancy. Despite culture for over 50
passages considerable variation in chromosome
number persists within the line. Despite this
variation, the growth rate determined between
passages 32-50 has remained constant and the
expression of cytoplasmic and cell membrane
antigens within the cell line is relatively consistent
from cell to cell. This suggests the heterogeneity in
chromosomal number is due to the instability of
near tetraploid cells, rather than due to several
contaminating cell populations. Currently the line is
being cloned to determine whether any stable
variant can be established from the original culture.
It is proposed that this in vitro cell line is suitable
material for studying the biology of rare tumours
such as rhabdomyosarcoma, as well as a source of
cells which can legitimately be used as immunogen
for raising and screening monoclonal antibodies to
rhabdomyosarcoma.
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